INTT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INTT is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 to deploy. The stock has some constructive signs from the latest analyst target increase and better-than-expected Q1 results, but the current technical setup is only neutral and the proprietary trading signals are absent. My direct view: hold off on buying aggressively at this moment and wait for clearer confirmation or a better entry.
INTT is trading pre-market at 15.94, below the analyst’s updated $15 target? No, it is slightly above that target when considering the related latest price context around 16.79 from options data, which suggests limited upside near-term. The MACD histogram is -0.197 and still below zero, showing bearish momentum though it is weakening. RSI_6 at 55.4 is neutral, so there is no strong overbought or oversold signal. Moving averages are converging, which usually reflects indecision rather than a strong trend. Key levels: pivot 16.128, resistance 17.213 and 17.883, support 15.043 and 14.373. Overall trend is sideways to slightly mixed, not a clean breakout setup.
Northland raised its price target on inTEST to $15 from $14 and maintained a Market Perform rating after better-than-expected Q1 results and modestly raised FY26 guidance. Options positioning is bullish with low put-call ratios, which supports constructive sentiment. The stock trend model suggests a mildly positive near-term drift. No negative news was reported in the last week.
There is no AI Stock Picker signal today and no recent SwingMax signal, so there is no proprietary trading confirmation. Technical momentum is not strong, with MACD still negative. Analyst view remains only Market Perform, which is not a strong endorsement. Hedge funds and insiders are both neutral, showing no strong accumulation signal. No recent news catalysts are present, so near-term upside may be limited.
Latest quarter: Q1, and the company reported better-than-expected Q1 results with modestly raised FY26 guidance. That indicates improving growth trends and a somewhat better forward outlook. However, the provided financial snapshot is incomplete, so deeper revenue, earnings, and margin analysis is not available here.
Recent analyst trend is mildly positive: Northland’s Ted Jackson raised the price target from $14 to $15 after Q1 beat and guidance improvement, while keeping a Market Perform rating. That is constructive but still neutral overall. Wall Street pros appear balanced-to-cautious: there is some optimism on results and guidance, but not enough conviction to label the stock a strong buy.
